Aaron Langdon
Overview
Explore the profile of Aaron Langdon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Langdon A, Grohe B
Colloids Surf B Biointerfaces
. 2016 Jul;
146:296-306.
PMID: 27362921
The protein osteopontin (OPN) plays an important role in preventing the formation of calcium oxalate monohydrate (COM) kidney stones. To gain insight into these mechanisms, crystallization was induced by addition...
2.
Grohe B, Hug S, Langdon A, Jalkanen J, Rogers K, Goldberg H, et al.
Langmuir
. 2012 Jul;
28(33):12182-90.
PMID: 22838385
Scanning confocal interference microscopy (SCIM) and molecular dynamics (MD) simulations were used to investigate the adsorption of the synthetic polypeptide poly(l-glutamic acid) (poly-glu) to calcium oxalate monohydrate (COM) crystals and...
3.
Grohe B, OYoung J, Langdon A, Karttunen M, Goldberg H, Hunter G
Cells Tissues Organs
. 2011 May;
194(2-4):176-81.
PMID: 21555861
Because of its ability to inhibit the growth of calcium oxalate monohydrate (COM) crystals, citrate plays an important role in preventing the formation of kidney stones. To determine the mechanism...
4.
Langdon A, Wignall G, Rogers K, Sorensen E, Denstedt J, Grohe B, et al.
Calcif Tissue Int
. 2009 Feb;
84(3):240-8.
PMID: 19189038
Proteins that inhibit the growth and aggregation of calcium oxalate crystals play important roles in the prevention of kidney stone disease. One such protein is osteopontin (OPN), which inhibits the...